Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (51-60 of 421) with videos related to

Pageof 43
Sort By:
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Need for expanded HPV genotyping for cervical screeningJack Cuzick, Cosette Wheeler
British Journal of Cancer|September 14, 2022
Interpreting the results of noninferiority trials-a reviewJack Cuzick, Peter Sasieni
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccinationPeter Sasieni, Jack Cuzick
Expert Review of Endocrinology & Metabolism|July 31, 2018
Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitorsIvana Šestak, Jack Cuzick
Breast Cancer Research : BCR|December 25, 2009
Risk factors. Introduction to Session 1Anthony Howell, Jack Cuzick
Cancer Letters|October 22, 2008
International agreement to join forces in synthesizing evidence on new methods for cervical cancer preventionMarc Arbyn, Jack Cuzick
Current Oncology Reports|October 12, 2013
Role of aspirin in cancer preventionMangesh A Thorat, Jack Cuzick
Vaccine|July 22, 2008
Cervical cancer screening following prophylactic human papillomavirus vaccinationEduardo L Franco, Jack Cuzick
European Journal of Epidemiology|November 26, 2014
Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general populationMangesh A Thorat, Jack Cuzick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancerAman U Buzdar, Jack Cuzick
Pageof 43

Showing results (51-60 of 421) with videos related to

Sort By:
Pageof 43
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Need for expanded HPV genotyping for cervical screeningJack Cuzick, Cosette Wheeler
British Journal of Cancer|September 14, 2022
Interpreting the results of noninferiority trials-a reviewJack Cuzick, Peter Sasieni
Lancet (London, England)|January 24, 2020
Population-level impact of human papillomavirus vaccinationPeter Sasieni, Jack Cuzick
Expert Review of Endocrinology & Metabolism|July 31, 2018
Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitorsIvana Šestak, Jack Cuzick
Breast Cancer Research : BCR|December 25, 2009
Risk factors. Introduction to Session 1Anthony Howell, Jack Cuzick
Cancer Letters|October 22, 2008
International agreement to join forces in synthesizing evidence on new methods for cervical cancer preventionMarc Arbyn, Jack Cuzick
Current Oncology Reports|October 12, 2013
Role of aspirin in cancer preventionMangesh A Thorat, Jack Cuzick
Vaccine|July 22, 2008
Cervical cancer screening following prophylactic human papillomavirus vaccinationEduardo L Franco, Jack Cuzick
European Journal of Epidemiology|November 26, 2014
Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general populationMangesh A Thorat, Jack Cuzick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancerAman U Buzdar, Jack Cuzick
Pageof 43